KORU Medical Systems, Inc.

NasdaqCM:KRMD Stock Report

Market Cap: US$183.8m

KORU Medical Systems Balance Sheet Health

Financial Health criteria checks 5/6

KORU Medical Systems has a total shareholder equity of $17.7M and total debt of $402.0K, which brings its debt-to-equity ratio to 2.3%. Its total assets and total liabilities are $27.4M and $9.7M respectively.

Key information

2.3%

Debt to equity ratio

US$401.99k

Debt

Interest coverage ration/a
CashUS$8.81m
EquityUS$17.73m
Total liabilitiesUS$9.66m
Total assetsUS$27.39m

Recent financial health updates

Recent updates

KORU Medical Systems, Inc. (NASDAQ:KRMD) Released Earnings Last Week And Analysts Lifted Their Price Target To US$4.10

Nov 16
KORU Medical Systems, Inc. (NASDAQ:KRMD) Released Earnings Last Week And Analysts Lifted Their Price Target To US$4.10

Impressive Turnaround At KORU Medical

Nov 06

We're Interested To See How KORU Medical Systems (NASDAQ:KRMD) Uses Its Cash Hoard To Grow

Aug 29
We're Interested To See How KORU Medical Systems (NASDAQ:KRMD) Uses Its Cash Hoard To Grow

KORU Medical Systems, Inc. (NASDAQ:KRMD) Doing What It Can To Lift Shares

Jul 30
KORU Medical Systems, Inc. (NASDAQ:KRMD) Doing What It Can To Lift Shares

Market Cool On KORU Medical Systems, Inc.'s (NASDAQ:KRMD) Revenues

Feb 15
Market Cool On KORU Medical Systems, Inc.'s (NASDAQ:KRMD) Revenues

We're Hopeful That KORU Medical Systems (NASDAQ:KRMD) Will Use Its Cash Wisely

Sep 21
We're Hopeful That KORU Medical Systems (NASDAQ:KRMD) Will Use Its Cash Wisely

Market Cool On KORU Medical Systems, Inc.'s (NASDAQ:KRMD) Earnings Pushing Shares 28% Lower

Jul 14
Market Cool On KORU Medical Systems, Inc.'s (NASDAQ:KRMD) Earnings Pushing Shares 28% Lower

We're Not Very Worried About KORU Medical Systems' (NASDAQ:KRMD) Cash Burn Rate

Sep 27
We're Not Very Worried About KORU Medical Systems' (NASDAQ:KRMD) Cash Burn Rate

Repro Med Systems (NASDAQ:KRMD) Is In A Good Position To Deliver On Growth Plans

Oct 27
Repro Med Systems (NASDAQ:KRMD) Is In A Good Position To Deliver On Growth Plans

Analysts Have Been Trimming Their Repro Med Systems, Inc. (NASDAQ:KRMD) Price Target After Its Latest Report

Aug 14
Analysts Have Been Trimming Their Repro Med Systems, Inc. (NASDAQ:KRMD) Price Target After Its Latest Report

Is Repro Med Systems, Inc.'s (NASDAQ:KRMD) Shareholder Ownership Skewed Towards Insiders?

Feb 22
Is Repro Med Systems, Inc.'s (NASDAQ:KRMD) Shareholder Ownership Skewed Towards Insiders?

Returns On Capital At Repro Med Systems (NASDAQ:KRMD) Paint An Interesting Picture

Jan 27
Returns On Capital At Repro Med Systems (NASDAQ:KRMD) Paint An Interesting Picture

Financial Position Analysis

Short Term Liabilities: KRMD's short term assets ($18.9M) exceed its short term liabilities ($6.3M).

Long Term Liabilities: KRMD's short term assets ($18.9M) exceed its long term liabilities ($3.3M).


Debt to Equity History and Analysis

Debt Level: KRMD has more cash than its total debt.

Reducing Debt: KRMD's debt to equity ratio has increased from 0% to 2.3% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: KRMD has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: KRMD has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 30.3% each year


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/08 05:46
End of Day Share Price 2025/01/08 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

KORU Medical Systems, Inc. is covered by 11 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Neil ChatterjiB. Riley Securities, Inc.
Kyle BauserB. Riley Securities, Inc.
Kyle RoseCanaccord Genuity